Mr John Sheridan, LCSW in Aloha, OR - Social Worker

Mr John Sheridan, LCSW is a Social Worker - Clinical based in Aloha, Oregon. Mr John Sheridan is licensed to practice in Oregon (license number L4487) and his current practice location is 20595 Sw Tv Hwy, Aloha, Oregon. He can be reached at his office (for appointments etc.) via phone at (503) 277-3077.

NPI number for Mr John Sheridan is 1932438876 and his current mailing address is 931 Se Albertine St, Hillsboro, Oregon. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1932438876.

Contact Information

	Mr John Sheridan, LCSW
	20595 Sw Tv Hwy, Aloha, OR 97006-1767
	(503) 277-3077
	Not Available

Healthcare Provider's Profile

Full Name	Mr John Sheridan
Gender	Male
Speciality	Social Worker - Clinical
Location	20595 Sw Tv Hwy, Aloha, Oregon
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1932438876
Provider Enumeration Date: 12/23/2009
Last Update Date: 12/23/2009

Medical Identifiers

Medical identifiers for Mr John Sheridan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1932438876	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	L4487 (Oregon)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr John Sheridan is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr John Sheridan, LCSW 931 Se Albertine St, Hillsboro, OR 97123-5191 Ph: (503) 277-3077	Mr John Sheridan, LCSW 20595 Sw Tv Hwy, Aloha, OR 97006-1767 Ph: (503) 277-3077

News Archive

Calithera Biosciences completes Series A financing totaling $40M

Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.

Research into 2-million-year-old human fossils reveals how hearing pattern resembles chimpanzees

Research into human fossils dating back to approximately two million years ago reveals that the hearing pattern resembles chimpanzees, but with some slight differences in the direction of humans.

Lung cancer patients who received IMRT report less decline in their QOL

An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

Using clopidogrel, PPIs increases cardiac damage risk: Study

Patients with coronary artery disease undergoing stent implantation are often prescribed the antiplatelet drug, clopidogrel. This drug prevents blood clots, but is known to have a side-effect that can cause stomach bleeding. Consequently, many users are also prescribed a proton pump inhibitor (PPI). Now, however, a meta-analysis of almost 160,000 patients carried out at the Medical University of Vienna and Wilhelminenhospital, Vienna, has shown that simultaneous use of these drugs can increase the risk of cardiac damage.

Caucasians have a higher rate of HBV recurrence compared to Asian Americans and African Americans

According to the Centers for Disease Control and Prevention (CDC) 1.5 to 2 million Americans are infected with the hepatitis B virus (HBV). Prior studies have shown there to be significant racial differences in access to and outcomes of liver transplantation. Recently, doctors from across the U.S. conducted a multicenter retrospective-prospective study of the waitlist status and outcomes of liver transplant patients with HBV infection.

Social Worker in Aloha, OR

Kayla Olson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-619-1935
Lesley Dominic, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-591-9280
Sarah Schwitkis, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-591-9280 Fax: 503-848-2072
Barbara Anne Boyd, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-619-1949
Zinaida Krivoruk, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-591-9280
Mr. Matthew D Lauzon, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4585 Sw 185th Ave, Aloha, OR 97007 Phone: 503-619-1559 Fax: 503-848-2072
Eve Skosey-lalonde, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4585 Sw 185th Ave, Aloha, OR 97078 Phone: 503-591-9280 Fax: 503-848-2072

Mr John Sheridan, LCSW - Clinical Social Worker in Aloha, OR